Top Biotechnology & Medical Research stocks in Australia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Market Cap
Price to Earnings
Dividend Yield
au flag iconTLXTelix PharmaceuticalsAU$3.16bnn/an/a
au flag iconNEUNeuren PharmaceuticalsAU$2.00bn37.85n/a
au flag iconIMUImugeneAU$642.30mn/an/a
au flag iconPYCPYC TherapeuticsAU$375.82mn/an/a
au flag iconIMMImmutepAU$356.19mn/an/a
au flag iconCU6Clarity PharmaceuticalsAU$354.50mn/an/a
au flag iconMSBMesoblastAU$329.53mn/an/a
au flag iconOPTOptheaAU$303.47mn/an/a
au flag iconCGSCogstateAU$248.52m46.85n/a
au flag iconRACRace OncologyAU$138.61mn/an/a
au flag iconPARParadigm BiopharmaceuticalsAU$122.42mn/an/a
au flag iconPIQProteomics International LaboratoriesAU$111.30mn/an/a
au flag iconBITBiotronAU$83.88mn/an/a
au flag iconALAArovella TherapeuticsAU$79.89mn/an/a
au flag iconOCCOrthocellAU$75.96mn/an/a
au flag iconPTXPrescient TherapeuticsAU$72.47mn/an/a
au flag iconADOAnteotechAU$67.65mn/an/a
au flag iconACWActinogen MedicalAU$55.41mn/an/a
au flag iconDXBDimerixAU$54.33mn/an/a
au flag iconIIQInoviqAU$54.29mn/an/a